Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma

Kai Fu, Javeed Iqbal, Wing C. Chan

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

The field of molecular diagnostics is changing and adapting to new information obtained from genetic, genomic and proteomic profiling of diseases. One of the novel technologies that has made significant impact on the molecular diagnosis of lymphoid malignancies is DNA microarray technology. It has allowed the profiling of the most common types of lymphomas, identifying distinct molecular signatures of these diseases as well as novel subtypes that cannot otherwise be identified by conventional methods. In addition, it has also allowed the construction of molecularly defined prognostic models for various types of lymphomas and to better understand the molecular mechanisms that determine the behavior of the tumor. In this review, recent advances in the molecular diagnosis of diffuse large B-cell lymphoma are highlighted, using examples of how gene expression profiling has been used in disease classification and outcome predictions. The future development of this field and its applications in the clinical arena will also be discussed.

Original languageEnglish (US)
Pages (from-to)397-408
Number of pages12
JournalExpert Review of Molecular Diagnostics
Volume5
Issue number3
DOIs
StatePublished - May 1 2005

Fingerprint

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Technology
Molecular Pathology
Gene Expression Profiling
Oligonucleotide Array Sequence Analysis
Proteomics
Neoplasms

Keywords

  • Classification
  • Diffuse large B-cell lymphoma
  • Gene expression profiling
  • Prognosis
  • Targeted therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma. / Fu, Kai; Iqbal, Javeed; Chan, Wing C.

In: Expert Review of Molecular Diagnostics, Vol. 5, No. 3, 01.05.2005, p. 397-408.

Research output: Contribution to journalReview article

@article{a52f8d53fd5e40aaaea1710d08541f9b,
title = "Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma",
abstract = "The field of molecular diagnostics is changing and adapting to new information obtained from genetic, genomic and proteomic profiling of diseases. One of the novel technologies that has made significant impact on the molecular diagnosis of lymphoid malignancies is DNA microarray technology. It has allowed the profiling of the most common types of lymphomas, identifying distinct molecular signatures of these diseases as well as novel subtypes that cannot otherwise be identified by conventional methods. In addition, it has also allowed the construction of molecularly defined prognostic models for various types of lymphomas and to better understand the molecular mechanisms that determine the behavior of the tumor. In this review, recent advances in the molecular diagnosis of diffuse large B-cell lymphoma are highlighted, using examples of how gene expression profiling has been used in disease classification and outcome predictions. The future development of this field and its applications in the clinical arena will also be discussed.",
keywords = "Classification, Diffuse large B-cell lymphoma, Gene expression profiling, Prognosis, Targeted therapy",
author = "Kai Fu and Javeed Iqbal and Chan, {Wing C.}",
year = "2005",
month = "5",
day = "1",
doi = "10.1586/14737159.5.3.397",
language = "English (US)",
volume = "5",
pages = "397--408",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Recent advances in the molecular diagnosis of diffuse large B-cell lymphoma

AU - Fu, Kai

AU - Iqbal, Javeed

AU - Chan, Wing C.

PY - 2005/5/1

Y1 - 2005/5/1

N2 - The field of molecular diagnostics is changing and adapting to new information obtained from genetic, genomic and proteomic profiling of diseases. One of the novel technologies that has made significant impact on the molecular diagnosis of lymphoid malignancies is DNA microarray technology. It has allowed the profiling of the most common types of lymphomas, identifying distinct molecular signatures of these diseases as well as novel subtypes that cannot otherwise be identified by conventional methods. In addition, it has also allowed the construction of molecularly defined prognostic models for various types of lymphomas and to better understand the molecular mechanisms that determine the behavior of the tumor. In this review, recent advances in the molecular diagnosis of diffuse large B-cell lymphoma are highlighted, using examples of how gene expression profiling has been used in disease classification and outcome predictions. The future development of this field and its applications in the clinical arena will also be discussed.

AB - The field of molecular diagnostics is changing and adapting to new information obtained from genetic, genomic and proteomic profiling of diseases. One of the novel technologies that has made significant impact on the molecular diagnosis of lymphoid malignancies is DNA microarray technology. It has allowed the profiling of the most common types of lymphomas, identifying distinct molecular signatures of these diseases as well as novel subtypes that cannot otherwise be identified by conventional methods. In addition, it has also allowed the construction of molecularly defined prognostic models for various types of lymphomas and to better understand the molecular mechanisms that determine the behavior of the tumor. In this review, recent advances in the molecular diagnosis of diffuse large B-cell lymphoma are highlighted, using examples of how gene expression profiling has been used in disease classification and outcome predictions. The future development of this field and its applications in the clinical arena will also be discussed.

KW - Classification

KW - Diffuse large B-cell lymphoma

KW - Gene expression profiling

KW - Prognosis

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=18844393117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18844393117&partnerID=8YFLogxK

U2 - 10.1586/14737159.5.3.397

DO - 10.1586/14737159.5.3.397

M3 - Review article

C2 - 15934816

AN - SCOPUS:18844393117

VL - 5

SP - 397

EP - 408

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 3

ER -